/
Cyteir Therapeutics, Inc.
A clinical-stage biotechnology company focused on developing cancer therapies. It was listed on Nasdaq under the ticker CYT and dissolved in March 2024.
Mentions
2 mentions · latest on 1 Jan 2025
| Generals and WorkoutsBlog | 2024 Portfolio Review | - | 1 Jan 2025 |
| Generals and WorkoutsBlog | 2023 Year End Portfolio Review | - | 31 Dec 2023 |